• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锝(III)膦配合物作为多药耐药性P-糖蛋白的转运底物及血脑屏障处P-糖蛋白功能标志物的表征

Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.

作者信息

Luker G D, Rao V V, Crankshaw C L, Dahlheimer J, Piwnica-Worms D

机构信息

Laboratory of Molecular Radiopharmacology, Department of Radiology, Washington University Medical School, St. Louis, Missouri 63110, USA.

出版信息

Biochemistry. 1997 Nov 18;36(46):14218-27. doi: 10.1021/bi971931z.

DOI:10.1021/bi971931z
PMID:9369495
Abstract

The multidrug resistance (MDR1) P-glycoprotein functions as a broad specificity efflux transporter of structurally diverse natural product and xenobiotic compounds. P-glycoprotein also is an important component of the functional blood-brain barrier. To enable further studies of function and modulation of MDR1 P-glycoprotein in vitro and in vivo, two novel phosphine technetium(III) complexes were designed and characterized: trans-[2,2'-(1, 2-ethanediyldiimino)bis(1, 5-methoxy-5-methyl-4-oxo-hexenyl)]bis[methylbis(3-methoxy-1- propyl)ph osphine]Tc(III) (Tc-Q58) and trans-[5,5'-(1,2-ethanediyl diimino)bis(2-ethoxy-2-methyl-3-oxo-4-pentenyl)]bis[dimethyl(3- methox y-1-propyl)phosphine)]Tc(III) (Tc-Q63). In human drug-sensitive KB 3-1 cells and multidrug-resistant KB 8-5 and 8-5-11 derivative cell lines, expressing nonimmunodetectable, low, and high levels of MDR1 P-glycoprotein, respectively, accumulation of Tc-Q58 and Tc-Q63 was inverse to expression of the transporter. Differences between drug-sensitive and multidrug-resistant cells, while detectable at picomolar concentrations of each radiopharmaceutical, were independent of tracer concentration. Ratios of tracer accumulation in KB 3-1 and 8-5 cells were 62.3 and 48.1 for Tc-Q58 and Tc-Q63, respectively. Cell contents of Tc-Q58 and Tc-Q63 were enhanced up to 60-fold in MDR cells by known modulators of MDR1 P-glycoprotein, while drugs not in the multidrug-resistant phenotype had no effect on their accumulation. In KB 8-5 cells, potency of modulators was GF120918 >> cyclosporin A > verapamil. Accumulation of Tc-Q58 and Tc-Q63 in Sf9 insect cells infected with a recombinant baculovirus containing human MDR1 P-glycoprotein was reduced in a GF120918-reversible manner (EC50 </= 70 nM) compared with cells infected with a wild-type baculovirus. By contrast, cell contents of Tc-Q58 or Tc-Q63 in Sf9 cells expressing the homologous MDR3 P-glycoprotein did not differ from wild-type virus. Demonstrating molecular targeting of these complexes in vivo, distribution and retention of Tc-Q58 in brain tissue of FVB mice treated with a saturating dose of GF120918 and mice deficient in the mdr1a gene [mdr1a (-/-)] were enhanced 180% and 520% over control, respectively. Exploiting the gamma-emission spectrum of 99mTc, increased uptake of Tc-Q58 in brain tissue of mdr1a (-/-) mice was readily detected noninvasively by scintigraphic imaging. Thus, both Tc-Q58 and Tc-Q63 are demonstrated to be substrates for transport by MDR1 P-glycoprotein, broadening the specificity of this transporter to include phosphine-containing metal complexes. As shown with Tc-Q58, these Q complexes can be used to detect transport activity and modulation of MDR1 P-glycoprotein in vitro and to directly monitor the functional status of P-glycoprotein at the blood-brain barrier in vivo.

摘要

多药耐药(MDR1)P-糖蛋白作为结构多样的天然产物和外源性化合物的广泛特异性外排转运体发挥作用。P-糖蛋白也是功能性血脑屏障的重要组成部分。为了能够在体外和体内进一步研究MDR1 P-糖蛋白的功能及其调节作用,设计并表征了两种新型的膦锝(III)配合物:反式-[2,2'-(1,2-乙二胺二亚氨基)双(1,5-甲氧基-5-甲基-4-氧代己烯基)]双[甲基双(3-甲氧基-1-丙基)膦]Tc(III)(Tc-Q58)和反式-[5,5'-(1,2-乙二胺二亚氨基)双(2-乙氧基-2-甲基-3-氧代-4-戊烯基)]双[二甲基(3-甲氧基-1-丙基)膦]Tc(III)(Tc-Q63)。在人药物敏感的KB 3-1细胞以及多药耐药的KB 8-5和8-5-11衍生细胞系中,它们分别表达不可免疫检测的、低水平和高水平的MDR1 P-糖蛋白,Tc-Q58和Tc-Q63的蓄积与转运体的表达呈负相关。药物敏感细胞和多药耐药细胞之间的差异,虽然在每种放射性药物的皮摩尔浓度下均可检测到,但与示踪剂浓度无关。Tc-Q58和Tc-Q63在KB 3-1和8-5细胞中的示踪剂蓄积比分别为62.3和48.1。已知的MDR1 P-糖蛋白调节剂可使MDR细胞中Tc-Q58和Tc-Q63的细胞含量增加多达60倍,而不具有多药耐药表型的药物对它们的蓄积没有影响。在KB 8-5细胞中,调节剂的效力为GF120918 >> 环孢素A > 维拉帕米。与感染野生型杆状病毒的细胞相比,感染含人MDR1 P-糖蛋白的重组杆状病毒的Sf9昆虫细胞中Tc-Q58和Tc-Q63的蓄积以GF120918可逆的方式降低(EC50≤70 nM)。相比之下,表达同源MDR3 P-糖蛋白的Sf9细胞中Tc-Q58或Tc-Q63的细胞含量与野生型病毒无差异。在用饱和剂量的GF120918处理的FVB小鼠和mdr1a基因缺陷的小鼠[mdr1a(-/-)]的脑组织中,Tc-Q58的分布和滞留分别比对照增强了180%和520%,这证明了这些配合物在体内的分子靶向性。利用99mTc的γ发射光谱,通过闪烁成像可以很容易地无创检测到mdr1a(-/-)小鼠脑组织中Tc-Q58摄取的增加。因此,已证明Tc-Q58和Tc-Q63都是MDR1 P-糖蛋白转运的底物,拓宽了该转运体的特异性,使其包括含膦金属配合物。如Tc-Q58所示,这些Q配合物可用于体外检测MDR1 P-糖蛋白的转运活性及其调节作用,并直接监测体内血脑屏障处P-糖蛋白的功能状态。

相似文献

1
Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.锝(III)膦配合物作为多药耐药性P-糖蛋白的转运底物及血脑屏障处P-糖蛋白功能标志物的表征
Biochemistry. 1997 Nov 18;36(46):14218-27. doi: 10.1021/bi971931z.
2
Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.用于多药耐药性(MDR1)P-糖蛋白功能成像的新型锝(III)-Q配合物。
J Nucl Med. 1998 Jan;39(1):77-86.
3
Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.多药耐药蛋白1(MDR1)、多药耐药蛋白3(MDR3)、多药耐药相关蛋白1(MRP1)以及乳腺癌耐药蛋白/多药耐药相关蛋白/ATP结合盒转运蛋白(BCRP/MXR/ABCP)对锝-99m(99mTc)-替曲膦转运的影响
Biochem Pharmacol. 2000 Aug 1;60(3):413-26. doi: 10.1016/s0006-2952(00)00341-5.
4
Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.用于体内MDR1 P-糖蛋白转运活性单光子发射计算机断层扫描(SPECT)和正电子发射断层扫描(PET)的67Ga/68Ga放射性药物的表征:在多药耐药肿瘤和血脑屏障中的验证
J Nucl Med. 2005 Feb;46(2):354-64.
5
P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution.P-糖蛋白介导的抗HIV1核苷类药物阿巴卡韦的主动外排限制了细胞内蓄积及脑内分布。
Drug Metab Dispos. 2007 Nov;35(11):2076-85. doi: 10.1124/dmd.107.017723. Epub 2007 Aug 20.
6
P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.P-糖蛋白(MDR1/ABCB1)和乳腺癌耐药蛋白(BCRP/ABCG2)限制 JAK1/2 抑制剂 CYT387 在脑内的蓄积。
Pharmacol Res. 2013 Oct;76:9-16. doi: 10.1016/j.phrs.2013.06.009. Epub 2013 Jul 1.
7
P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib.P-糖蛋白和乳腺癌耐药蛋白影响达沙替尼在脑内的分布。
J Pharmacol Exp Ther. 2009 Sep;330(3):956-63. doi: 10.1124/jpet.109.154781. Epub 2009 Jun 2.
8
Characterization of a novel 99mTc-carbonyl complex as a functional probe of MDR1 P-glycoprotein transport activity.一种新型99mTc-羰基配合物作为MDR1 P-糖蛋白转运活性功能探针的表征
Mol Imaging. 2002 Jan-Mar;1(1):24-35. doi: 10.1162/15353500200200002.
9
In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results.P-糖蛋白介导转运的体外底物鉴定研究:物种差异及体内结果的可预测性
J Pharmacol Exp Ther. 2001 Mar;296(3):723-35.
10
The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice.乳腺癌耐药蛋白和P-糖蛋白对小鼠体内黄酮哌啶醇、甲磺酸伊马替尼(格列卫)、哌唑嗪和2-甲氧基-3-(4-(2-(5-甲基-2-苯基恶唑-4-基)乙氧基)苯基)丙酸(PF-407288)脑渗透的影响。
Drug Metab Dispos. 2009 May;37(5):946-55. doi: 10.1124/dmd.108.024489. Epub 2009 Feb 18.

引用本文的文献

1
A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion.一种用于心肌灌注PET成像的由发生器产生的镓-68放射性药物。
PLoS One. 2014 Oct 29;9(10):e109361. doi: 10.1371/journal.pone.0109361. eCollection 2014.
2
Cell-based and in vivo spectral analysis of fluorescent proteins for multiphoton microscopy.基于细胞的和活体的荧光蛋白的光谱分析用于多光子显微镜。
J Biomed Opt. 2012 Sep;17(9):96001. doi: 10.1117/1.JBO.17.9.096001.
3
Evaluation of (64)Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance.
评估(64)Cu(DO3A-xy-TPEP)作为监测肿瘤多药耐药性的潜在正电子发射断层显像(PET)放射性示踪剂。
Bioconjug Chem. 2009 Apr;20(4):790-8. doi: 10.1021/bc800545e.
4
Imaging chemokine receptor dimerization with firefly luciferase complementation.利用萤火虫荧光素酶互补成像趋化因子受体二聚化
FASEB J. 2009 Mar;23(3):823-34. doi: 10.1096/fj.08-116749. Epub 2008 Nov 10.
5
N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk.N-(4-[2-(1,2,3,4-四氢-6,7-二甲氧基-2-异喹啉基)乙基]-苯基)-9,10-二氢-5-甲氧基-9-氧代-4-吖啶甲酰胺(GF120918)作为一种化学三磷酸腺苷结合盒转运体家族G成员2(Abcg2)基因敲除模型,用于研究呋喃妥因向乳汁中的转运。
Drug Metab Dispos. 2008 Dec;36(12):2591-6. doi: 10.1124/dmd.108.021980. Epub 2008 Sep 17.
6
A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies.一种使用锝-99m 甲氧基异丁基异腈评估心肌病患者心脏线粒体功能的新型临床指标。
J Nucl Cardiol. 2007 Apr;14(2):215-20. doi: 10.1016/j.nuclcard.2006.10.022.
7
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.血脑屏障处的P-糖蛋白缺乏会增加阿尔茨海默病小鼠模型中的β-淀粉样蛋白沉积。
J Clin Invest. 2005 Nov;115(11):3285-90. doi: 10.1172/JCI25247. Epub 2005 Oct 20.
8
Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.P-糖蛋白对HIV蛋白酶抑制剂安普那韦(141W94)中枢神经系统分布的作用。
Pharm Res. 1999 Aug;16(8):1206-12. doi: 10.1023/a:1018941328702.
9
Pathways of As(III) detoxification in Saccharomyces cerevisiae.酿酒酵母中砷(III)解毒途径。
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5001-6. doi: 10.1073/pnas.96.9.5001.
10
Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.脉络丛上皮细胞中多药耐药蛋白1(MDR1)P糖蛋白和多药耐药相关蛋白的表达有助于形成血脑-脑脊液药物渗透屏障。
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3900-5. doi: 10.1073/pnas.96.7.3900.